April 23, 2004, ST. LOUIS -- Timothy J. Eberlein, MD, FACS, director of the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, has been named editor-in-chief of the Journal of the American College of Surgeons (JACS).
JACS is a monthly peer-reviewed journal publishing original contributions on all aspects of surgery and is the official scientific publication of the American College of Surgeons. It is one of the largest surgical journals in the world with over 66,000 subscribers.
"It is a tremendous honor to assume the leadership of the Journal of the American College of Surgeons. JACS is approaching 100 years of publishing important findings that directly influence the science and art of surgery. The challenge for JACS, which represents the largest and most broadly based surgical organization, is to become even more meaningful for all our members and to do so in the context of the electronic age," says Dr. Eberlein.
Since 1998, Dr. Eberlein has been Bixby Professor and chairman of the department of surgery at Washington University School of Medicine as well as Spencer T. and Ann W. Olin Distinguished Professor at WUSM and surgeon-in-chief at Barnes-Jewish Hospital.
Dr. Eberlein has been a Fellow of the College since 1998 and a member of the Surgical Research and Education Committee since 1994 (Vice-Chair, 1998-2000; Chair, 2000-2002) and as a member of that committee''s Executive Committee, Corporate Research Roundtable (1994-2002). Dr. Eberlein has been a member of the Commission on cancer since 1995, and of the ACS Committee for the Forum on Fundamental Surgical Problems since 1997 (Vice-Chair, 2000-present). He has served on the steering committee for the ACS Surgical Oncology Trials Group (1994-present) and is a member of the group''s Executive Committee. Since 1996 he has served as the College''s representative to the Inherited Susceptibility to Breast and Ovarian Cancer Task Force.
The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is an international leader in patient care, cancer research, prevention, education and community outreach and a National Cancer Institute-designated Cancer Center. It is the only cancer center with this designation in Missouri and within a 240-mile radius of St. Louis.